Missed Abortion Clinical Trial
Official title:
Comparative Study Between Operative Hysteroscopy Versus the Ultrasound Guided Vacuum Aspiration Versus the Blind Vacuum Aspiration for the Treatment of the Missed Abortion
The intervention to be evaluated are operative hysteroscopy(group A) and ultrasound guided
aspiration(group C) and blinded vacuum aspiration(group B).
For all surgical procedures , surgical antibiotics prophylaxis, misoprostol to dilate
cervix, and anti adhesion barrier gel will be used. The evacuated retention products will be
sent for pathological examination.
Group A: Operative Hystroscopy:
The procedure will be performed under general anaesthesia with the patient in lithotomy
position. the cervix is grasped with pozzi forceps and dilated up to hegar 9 to facilitate
insertion of the hysteroscopy. The uterine cavity will be distended with saline or glycine,
with a maximum irrigation pressure of 110mmHg. The retained products will be resected from
top to bottom with surgical resector without electric power. The use of forceps or curettes
to facilitate the removal of material is permitted. .
Group B:blinded vacuum aspiration of gestational contents:
The women were allowed to empty their urinary bladder before induction of anesthesia, After
positioning the patient appropriately on the operating table, bimanual pelvic examination
was performed under anesthesia to assess the axis and the size of the uterus. A Sim's
speculum was inserted into the vagina; the cervix was visualized and grasped using the
Vulsellum forceps. The cervical canal was dilated gradually with Hegar dilators up to the
size corresponding to the weeks of gestation. The uterine cavity was evacuated using a
plastic cannula attached to an electric suction apparatus. Negative pressure of 75 mmHg was
used. The aspirate was examined to confirm the presence of products of conception. The
completeness of the evacuation was checked by gentle sharp curettage and final suctioning at
the end of procedure.
Group C: Ultrasound guided aspiration curettage :
same as group B but guided with ultrasound
Status | Recruiting |
Enrollment | 300 |
Est. completion date | December 2017 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 39 Years |
Eligibility |
Inclusion Criteria: - Women in the fertility perioddiagnosed with missed abortion in the first trimester < 14 wks of gestation. The pregnancy concerned should correspond to a planned or wanted baby. Diagnosis of missed abortion by transvaginal ultrasound showing sgestational sac with no cardiac pulsations. Exclusion Criteria: - • Other type of abortion. - Known uterine malformation. - History of surgical intervention done in the uterus or uterine cavity. - Moderate to sever vaginal bleeding needing rapid surgical intervention. - Presence of IUD - Current pregnancy obtained by IVF cycle - Extrauterine pregnancy |
Country | Name | City | State |
---|---|---|---|
Egypt | Kasr Alainy medical school | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pregnancy rate after evacuation | duration needed to achieve pregnancy after evacuation provided non use of contraceptive methods | 12 months after procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01639976 -
Doppler Flow Measurements in Patients With Misoprostol Treatment for Arrested Pregnancy
|
N/A | |
Recruiting |
NCT03628625 -
Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage
|
Phase 2 | |
Completed |
NCT03584698 -
Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage
|
Phase 4 | |
Active, not recruiting |
NCT05516810 -
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
|
||
Not yet recruiting |
NCT04590482 -
Letrozole Pretreatment With Misoprostol Induction of Abortion in First Trimester Missed Abortion
|
Phase 4 | |
Recruiting |
NCT05342467 -
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
|
Phase 2 | |
Recruiting |
NCT03698734 -
Evening Primrose Oil Efficacy in Second Trimester Abortion
|
Phase 3 | |
Terminated |
NCT01615224 -
Repeated Doses of Misoprostol for Medical Treatment of Missed Miscarriage
|
Phase 2/Phase 3 | |
Completed |
NCT05216952 -
Ulipristal Acetate for Use in Early Pregnancy Loss
|
Phase 2 | |
Completed |
NCT00892229 -
Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil
|
Phase 2 | |
Active, not recruiting |
NCT04981457 -
Comparative Study Between Combined Vaginal Misoprostol
|
Phase 1 | |
Not yet recruiting |
NCT06469203 -
Oxytocin Effectiveness in First Trimester Dilatation and Curettage - a Double Blind Placebo Controlled Randomized Trial
|
N/A | |
Recruiting |
NCT02573051 -
Termination Of Anembryonic Pregnancy
|
Phase 2 | |
Not yet recruiting |
NCT04215835 -
Letrozole Pretreatment With Misoprostol Induction of Abortion In First-Trimester Missed Miscarriage
|
Phase 4 | |
Not yet recruiting |
NCT04217265 -
Letrozole Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion
|
Phase 4 | |
Recruiting |
NCT04705324 -
Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion
|
N/A | |
Completed |
NCT02686840 -
Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage
|
Phase 3 | |
Terminated |
NCT02342002 -
Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial
|
Phase 4 | |
Recruiting |
NCT01775917 -
The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception.
|
N/A | |
Active, not recruiting |
NCT04593108 -
Misoprostol With or Without Letrozole in Treatment of Missed Miscarriage
|